into this transaction is consistent with the strategic plan in the business operation of the Company, which emphasizes on investment expansion in line with the strategy aiming at growth alongside the PTT

Acquisition of Assets and the Connected Transaction 2. Information Memorandum regarding the offering of the newly issued ordinary shares to specific investors (Private Placement) 3. Capital Increase Report Form

and sellers. 8. Benefits expected by the Company 1. Expansion of scope of business into the growth business related to health and aging society business which related and mutually supporting with main

to 400 days of Baht 23.04 million had not been included, the net profit of the Corporate Group for Year 2019 would be Baht 548.27 million or an increase of 29.66 percent. This was due to expansion of

. Meanwhile, farm income declined due to a more-severe-than expected impact of the drought. The Bank of Thailand reduced Thailand’s economic growth projection for 2020 to contract 5.3% (as of March 2020

profit of the Corporate Group for the 1st quarter 2019 would be Baht 165.62 million or an increase of 18.30 percent. Details of the changes or impacts are described in the Management Discussion and

Company 1. Expansion of scope of business into the growth business related to health and aging society business which related and mutually supporting with main business of the Company; medical devices and

million, the Corporate Group’s net profit for the year increased by Baht 4 .44 million or an increase of 3.28 percent. Details of the changes or impacts are described in the Management Discussion and

12.1% increase from Baht 422.7 million in 2Q2018 mainly due to increase of Other Utilties Revenue 2,236.6% YoY and Operating Revenue 0.2% YoY. The increase of Operating Revenue was attributable to growth

performance are as follows: Sales Revenue Sales revenue for Q2/2017 of 269.33 million baht shows an increase of 99.98 million baht or 59.04% y-o-y. Cost of sales of 172.40 million baht shows an increase of